Krishna Institute of Medical Sciences: The financial results for the period ended September 30, 2026
Krishna Institute of Medical Sciences (KIMS) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹30,681 crore.
What happened
Krishna Institute of Medical Sciences (KIMS) filed a disclosure with the exchanges on 4 November 2026 at 06:43 PM titled "The financial results for the period ended September 30, 2026".
From the filing: "Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026."
Company snapshot
Krishna Institute of Medical Sciences is a mid-cap company in the Healthcare sector, with a market value of about ₹30,681 crore.
The stock last traded at ₹730.5, against a 52-week range of ₹575.8–₹858 (14.9% below the high).
Before this filing the shares had moved −0.8% over the month and −8.9% over three months. Average daily turnover over the last 20 sessions was about ₹28.54 crore.
Promoters held 32.50% at the end of Q1 FY27; 10.26% of promoter shares were pledged. Foreign institutions owned 14.74% and domestic institutions 34.43%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 872 | 78.6 | 1.96 |
| Q2 FY26 | 961 | 67.1 | 1.67 |
| Q3 FY26 | 998 | 53.4 | 1.33 |
| Q4 FY26 | 1,075 | 42.5 | 1.06 |
| Q1 FY27 | 1,180 | 41.5 | 1.04 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Across 300 similar disclosures by other Healthcare companies, shares moved +1.4% on average the next day and +2.0% over five days; 58% of them rose the next day.
Market-wide, 10,609 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
Market reaction so far
Since the filing, the stock is unchanged, from ₹730.5 before the disclosure to ₹730.5 (live price).
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 4 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Krishna Institute of Medical Sciences acquires 51% stake in Sarvottam for ₹79.50 crore
- KIMS Legal Update: Chennai Hospital Project Continues Amid Ongoing Land Dispute
- Stocks in Focus: NCC, Krishna Institute, Affle 3i, and Others
- KIMS Plans 51% Sarvottam Stake in ₹80 Crore Healthcare Deal
- Krishna Institute of Medical Sciences acquires 5.82% stake in Ushahkal Hospital
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.